Composition with synergistic tyrosinase inhibition effect and application thereof
A technology of tyrosinase and synergistic inhibition is applied in the directions of drug combination, active ingredients of hydroxyl compounds, and medical preparations containing active ingredients, etc., which can solve the problems of high cost, unsatisfactory effect and high cost, and achieve the effect of reducing dosage.
Pending Publication Date: 2020-11-13
TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
There are many treatment techniques and anti-freckle products for chloasma, most of which are expensive and expensive; but the curative effect is not satisfactory, and almost all of them are accompanied by adverse reactions
Both resveratrol and phenylethylresorcinol have antioxidant and tyrosinase-inhibiting effects, but there is no research report on combining the two into a composition to inhibit tyrosinase
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] A composition with a synergistic inhibitory effect on tyrosinase consists of resveratrol and phenylethylresorcinol at a molar ratio of 30.
Embodiment 2
[0014] A composition with synergistic inhibitory effect on tyrosinase consists of resveratrol and phenylethylresorcinol in a molar ratio of 10.
Embodiment 3
[0016] A composition with a synergistic inhibitory effect on tyrosinase is composed of resveratrol and phenylethylresorcinol in a molar ratio of 8.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a composition with a tyrosinase inhibiting effect and an application thereof. The composition is prepared from resveratrol and phenethyl resorcinol according to the molar massratio of 0.03 to 30. Experiments prove that the composition disclosed by the invention has the effect of synergistically inhibiting tyrosinase, and can be used for treating chloasma, erythema after acne, freckles and senile plaques, repairing after sun exposure and resisting oxidation.
Description
technical field [0001] The invention relates to a composition with antioxidant activity, in particular to a composition and application with synergistic inhibition of tyrosinase. Background technique [0002] Chloasma is the most common melanosis disease, mostly occurs in the exposed parts of the face of young and middle-aged women, affects the appearance, and is difficult to treat at the same time. It is a major disease problem that is difficult to solve in the medical field. Its characteristics are: the onset is affected by many factors (ultraviolet stimulation, inflammatory response, etc.), stubborn, and easy to relapse. There are many treatment techniques and freckle products for chloasma, most of which are expensive and expensive; but the curative effect is unsatisfactory, and almost all of them are accompanied by adverse reactions. Both resveratrol and phenylethylresorcinol have antioxidant and tyrosinase-inhibiting effects, but there is no research report on combinin...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K31/05A61K8/34A61Q19/08A61Q19/00A61P17/16A61P17/18A61P17/00A61P17/10
CPCA61K8/347A61K31/05A61K2800/5922A61K2800/782A61Q19/004A61Q19/08A61P17/00A61P17/10A61P17/16A61P17/18A61K2300/00
Inventor 靳佳慧王艳刘轩鸣
Owner TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
Features
- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
Why Patsnap Eureka
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com